Product Description
Discover the rare and valorous Dasatinib 50 mg Tablets, precisely tailored for those seeking unassailable solutions in oncology care. Created by Natco Pharma Ltd., these rarefied oral tablets are white to off-white, round, and biconvex, imprinted with 'DAS 50'. As a potent tyrosine kinase inhibitor, this anticancer medication is uniquely personalised for adults battling Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Prescription required. Grab yours for a sophisticated approach to cancer therapy-administer only under expert medical supervision.
Exceptional Features and Versatile Applications
Dasatinib 50 mg Tablets offer advanced anti-cancer efficacy due to their potent tyrosine kinase inhibition, making them suitable for treating both Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Each tablet, to be taken orally at a fixed time daily as advised by a physician, exemplifies reliability and targeted performance. Their robust therapy profile is further strengthened by long shelf life, compact packaging, and broad area of application within hematologic malignancies.
Sample Availability, Certifications, and Export Supply
Samples of Dasatinib 50 mg Tablets are available upon qualified request, ensuring trust and transparency in procurement. Certified to meet stringent pharmaceutical standards, these tablets are ready for supply to main export markets across India and abroad. With streamlined delivery and efficient supply chain management, timely drop-off and support are ingrained in every transaction, upholding a reputation for quality and reliability worldwide.
FAQ's of Dasatinib 50 mg Tablets (60 tablets):
Q: How should Dasatinib 50 mg Tablets be taken for optimal effectiveness?
A: Dasatinib 50 mg Tablets should be taken orally, with or without food, at the same time each day, following the exact dosage prescribed by your physician.
Q: What are the main uses of Dasatinib 50 mg Tablets?
A: These tablets are mainly indicated for the treatment of Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) in adults.
Q: When is it necessary to consult a doctor during treatment?
A: It is imperative to consult your doctor if you experience any side effects such as myelosuppression, fluid retention, gastrointestinal disturbances, or rash, or if you have concerns about your treatment schedule.
Q: Where can Dasatinib 50 mg Tablets be stored for maximum lifespan?
A: These tablets should be stored below 30C, protected from moisture and light, to maintain efficacy throughout their 24-month shelf life.
Q: What are the benefits of using Dasatinib 50 mg Tablets over other therapies?
A: Dasatinib offers a rarefied, targeted approach, effectively inhibiting tyrosine kinases involved in cancer progression, thus delivering significant therapeutic advantage in CML and ALL management.